A Study of Patients With Pure Red Cell Aplasia Associated With Recombinant Human Erythropoietin Treatment
Clinical trial NCT00211042 · COMPLETED
Trial details
- NCT number
- NCT00211042
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2004-02-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.